M&A activity has ebbed in 2008 and its no surprise as history taught us recessionary environments tend to result in lower activity.
However, the phrase has been popping up quite actively in the news, in this month alone we have:
Mar 19: Cisco > Pure Digital Technologies (USD0.59B)
Mar 18: IBM > Sun (USD6.5B)
Mar 12: Roche > Genentech (USD46.8B)
Mar 9: Merck > Schering-Plough (USD41.1B)
Well...I can understand Counter-cyclical industries, such as healthcare might be able to see strength in M&A. As for the rest, does it mean they are distressed deals where sellers have no choice but to sell out?
No comments:
Post a Comment